injection site reaction glp-1 allergic to glp 1 Understanding Reactions with Medications Injection site reactions with #glp1
Description
Longer term: steady state and fuller effects With consistent weekly dosing, weight loss often continues gradually over many months before reaching a plateau
GLP1s+ are more complex to produce than typical small molecule oral tablets

The industry is actively seeking differentiated small molecule oral drugs that can overcome the limitations of current options

While current approved indications include obesity, type 2 diabetes, and cardio-renal complications, it is in the investigational space that we glimpse the future trajectory of this class: neurodegenerative diseases, systemic inflammatory conditions, psoriasis, hypertension, and type 1 diabetes

Pfizer ends oral GLP-1 candidate danuglipron due to liver injury

(accessed June 2022) 21Ozempic App UK
